Cargando…
Combined Treatment with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer-PPMO and AAV-U7 Rescues the Severe DMD Phenotype in Mice
Duchenne muscular dystrophy (DMD) is a devastating neuromuscular disease caused by an absence of the dystrophin protein, which is essential for muscle fiber integrity. Among the developed therapeutic strategies for DMD, the exon-skipping approach corrects the frameshift and partially restores dystro...
Autores principales: | Forand, Anne, Muchir, Antoine, Mougenot, Nathalie, Sevoz-Couche, Caroline, Peccate, Cécile, Lemaitre, Mégane, Izabelle, Charlotte, Wood, Matthew, Lorain, Stéphanie, Piétri-Rouxel, France |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177166/ https://www.ncbi.nlm.nih.gov/pubmed/32346547 http://dx.doi.org/10.1016/j.omtm.2020.03.011 |
Ejemplares similares
-
In Vitro Validation of Phosphorodiamidate Morpholino Oligomers
por: Aung-Htut, May T., et al.
Publicado: (2019) -
Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds
por: Nan, Yuchen, et al.
Publicado: (2018) -
Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers
por: Li, Chengxi, et al.
Publicado: (2021) -
Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD
por: Akpulat, Ugur, et al.
Publicado: (2018) -
MOTS‐c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice
por: Ran, Ning, et al.
Publicado: (2020)